Implementation and functionalities
In order to validate the reliability of the algorithm we implemented a cross-platform fast parallel computational tool, tfNet executables and user manual: http://figshare.com/articles/tfNet_manual/1408532 (1) (Supplementary Figure S1) . The key functionalities of the tool include strand-specific region detection, on-the-fly region filtering, statistically significant interactions of the genomic-signal pairs, output in the UCSC BED format and in the information-rich XML format. The tool is provided as a single executable file, the results can be visualized in genome browsers and the genomic signals interactions are modeled with weighted networks.
Construction of a null model of regions We created artificial datasets by applying the shuffleBed functionality of BEDTools v2.21(2) to a synthetic TF dataset constructed using the mean peak length (335bp) and the mean peak number (14633 peaks) of the full analysis dataset. We constructed collections of TFBS datasets varying from 1 to 1000 and we recursively ran our tfNet pipeline while observing the properties of the generated regulatory regions (quantity, genome coverage and time efficiency of the tool) (Supplementary Figure S4 and S19). For each run we computed the running time of tfNet on a 12 core Intel(R) Xeon(R) CPU X5650 @ 2.67GHz CentOS7 machine.
Supplementary Note S2: Data processing
Mus musculus data processing We downloaded transcription factor binding site data for Mus musculus from ENCODE (Supplementary Table S1 ) and renamed the downloaded files according to TF data they contained. We divided the TFBS files into 5 groups based on their cell line (C2C12, CH12.LX, ES-E14, MEL, myocyte). Finally, we merged TFBSs files originating from different replicates of the same TF and run the tfNet tool on the data (Methods -Identification of the regulatory landscape). The input data statistics and the number of putative regulatory regions calculated are presented in (Supplementary Table S7 ; Supplementary Figure S7A ). The TF interactions networks for each of the five cell lines are shown in (Supplementary Figure S8) .
Drosophila melanogaster data processing
We downloaded all the available TFBSs for drosophila melanogaster from modENCODE, Berkeley Drosophila Transcription Network Project (BDTNP) and Literature (5) (6) (7) (8) . We also downloaded all the available cis-regulatory elements (CRMs) from the redFly database (9) and the DNaseI hypersensitive sites from modENCODE (10) . All data sources, the corresponding URLs and the database download criteria are listed in (Supplementary Table S1 ). First we converted any gff3 files to BED format. Secondly, we merged TFBSs files originating from different replicates and different databases of the same TF, and run the tfNet tool on the data (Methods -Identification of the regulatory landscape). We named this analysis as cumulative. The input data statistics and the number of putative regulatory regions calculated are presented in (Supplementary Table S7 ; Supplementary Figure S7B ). The TF interactions networks for the cumulative dataset are shown in (Supplementary Figure S10) .
Next, we divided the data into developmental stages and selected those containing a sufficient number of TFs (Embryos 0-8, Embryos 0-12, Embryos 8-16 and Embryos 16-24). Then we merged TFBSs files originating from different replicates and different databases of the same TF, and run the tfNet tool on the data (Methods -Identification of the regulatory landscape). The input data statistics and the number of putative regulatory regions calculated are presented in (Supplementary Table S7 ; Supplementary Figure S7B) . The TF interactions networks for each of the four developmental stages is are shown in (Supplementary Figure S9) .
Colorectal cancer data processing
We downloaded all the high throughput (HT) ChIP-seq data generated by (11) (GSE49402). We used only the TF ChIP-seq peaks that had passed the quality control pipeline developed by (11) . In total we were left with 117 TFs. On average there were 13628 peaks per TF. We used the ENCODE liftOver tool to convert the genomic coordinates from hg18 to hg19 and then we run tfNet (Methods -Identification of the regulatory landscape).
Prostate cancer data processing We downloaded ChIP-seq raw data for multiple prostate cancer cell lines from (12) (Supplementary Table S6 ). We used only TF ChIP-seq experiments that were performed under normal conditions. We aligned the reads against hg19 with bwa (13) and we ran the ENCODE ChIP-seq peak calling pipeline based on Kundaje's Lab implementation (ENCODE3 pipeline v1 -https://github.com/kundajelab/TF_chipseq_pipeline) with MACS2 (14) . We used the overlapped peaks for each replicate since the Irreproducibility Discovery Rate (IDR) framework (15) could not be applied to the majority of the experiments due to lack of controls or lack of exactly 2 replicates per TF. We pooled TF replicates originating from different prostate cancer cell lines. We merged the overlapping TFBSs originating from different replicates or studies of the same TF into single peaks in order to avoid artefacts and misleading TF interactions (multiple peaks of the same TF originating from different replicates binding the same genomic loci) using the function mergeBed of bedtools (2). Next we run tfNet (Methods -Identification of the regulatory landscape).
Supplementary Note S3: Experimental Validations

Selection and validation of regulatory regions
The following steps were taken in order to select putative regulatory regions for experimental validation: (a) we created a list of keywords associated with various liver diseases (Supplementary Table S9 ). (b) we listed all SNPs from genome-wide association study catalogue (GWAS)(3)_ENREF_26 that contained any of the keywords in their description. (c) we used SNAP Annotation and Proxy Search tool v2.2(4)_ENREF_27 to find SNPs in linkage disequilibrium (r 2 =0.8) with the GWAS SNPs. (d) we selected putative regulatory regions from the pools of filtered regions that contained TFBSs with GWAS SNPs or SNPs in LD with GWAS SNPs. We found 17 putative regulatory regions that contained SNPs related to hepatocellular diseases. To obtain preliminary results of biological validation we selected 8 putative regulatory regions starting with the shortest ones. We adopted a hypothesis that the presence of putative regulatory region should significantly increase the signal of luciferase assay (protocol described in detail below).
Construction of cloning plasmids and luciferase report assays
The luciferase expression constructs were built based on pGL4.23 (Promega). The ccdB expression cassette was inserted into KpnI and EcoRV sites of pGL4.23 to construct pGL4.23-ccdB, which was used as a basal vector to diminish false positive signal during the cloning process. The designed primers (Sigma-Aldrich) amplified the putative regulatory region using Phusion Hot Start Flex DNA polymerase (NEB) and HepG2 genomic DNA as a template. The PCR product was separated on an agarose gel and followed by isolation of a specific gel band (QIAquick Gel Extraction Kit from QIAGEN). The purified amplification product was inserted upstream of the minimal promoter sequence of pGL4.23 by SLiCE cloning methods. In transformation step we used Library Efficiency® DH5α™ Competent Cells (life technologies) and followed the manufacturer's transformation procedure with minor changes. To annotate a SNP variant with a sequence of a putative regulatory region, multiple individual clones were picked up and subjected to Sanger sequencing. HepG2 cells were transfected using X-tremeGENE HP DNA Transfection Reagent (Roche), one day after plating with approximately 90% confluence in 96-well plate. Each well was transfected with 100 ng of firefly luciferase reporter vector harboring respective putative regulatory region together with 1 ng of renilla luciferase reporter vector pGL4.74, which was used to normalize the transfection and lysis efficiency. Twenty-four hours after transfection, the cells were harvested and lysed in 1X passive lysis buffer (Promega) on a rocking platform for 45 min at room temperature. Luminescence of firefly and luciferase activity were measured by Dual-Luciferase® Reporter (DLR™) Assay System (Promega) on an Infinite® M200 pro reader (TECAN) following the manufacturer's protocol. Simultaneously, we fulfilled the same procedure for an empty vector control. The luminescence measurements came from six replicate wells. The luciferase normalized ratios of experimental samples (Supplementary Table S5 ) were compared to empty vector using non-parametric MannWhitney test.
Supplementary Note S4: Gene expression level comparison
We compared the gene expression levels between promoters of genes annotated as heterochromatic, insulators and promoters from ChromHMM for 3 selected cell lines (GM12878, HepG2 and K562). The gene set together with the average reads per kilobase per million mapped reads (RPKM) was obtained from the Gene expression matrix over ENCODE2 in GENCODEv19 (Supplementary Table S1 ) and it constituted of 48807 genes. To obtain the gene coordinates we employed the GENCODEv23 gene annotations mapped to hg19 coordinates (Methods -Regulatory region annotation). Then we intersected the promoters ±1.5kb with putative regulatory regions of heterochromatic, insulator or promoter annotation for all three cell lines while maintaining the RPKM1 value information. In order to calculate the statistical difference between gene expression levels (p-value) for the annotations we used Wilcoxon ranksum test. 
